Description
AFNOBACT-50 — Faropenem-Based Protection for Everyday Bacterial Infections
AFNOBACT-50 contains Faropenem 50 mg, an oral penem antibiotic known for its stability against many beta-lactamase enzymes and its broad coverage across gram-positive and gram-negative organisms. Physicians often reach for faropenem in respiratory, ENT, and urinary infections where an oral option with dependable spectrum is needed without stepping up to injectable therapy. This balance of efficacy and convenience keeps the molecule in regular rotation across general practice, making AFNOBACT-50 a sound pick for franchise partners looking to diversify their antibiotic basket.
Manufacturing You Can Stand Behind
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company based in Panchkula, Haryana, with manufacturing carried out at our Baddi, Himachal Pradesh facility. AFNOBACT-50 is produced under controlled quality processes to ensure that potency and stability remain consistent from batch to batch, which matters directly to how confidently a doctor continues prescribing it. For a PCD pharma franchise company in India, this kind of manufacturing discipline is what helps field partners retain prescriber trust over time, not just secure a first order.
Product Highlights for Franchise Partners
- Composition: Faropenem 50 mg
- Dosage Form: Tablets
- Pack Size: 10x1x10
- Pack Type: Aluminium Strip for better moisture protection and shelf stability
- Key Benefit: Broad-spectrum protection supporting faster recovery from bacterial infections
- Suited For: Distributors and medical representatives expanding their anti-infective portfolio
Franchise partners interested in adding a penem-based antibiotic to their range can explore our full anti-infective line through our PCD pharma franchise division, along with promotional and field support material.
Disclaimer: This is a prescription antibiotic and should be used only under the supervision of a registered medical practitioner.
